C-peptide is released in exact lockstep with your own insulin production, one molecule per molecule of insulin made. Because it is not in injected insulin and clears more slowly, it is the cleanest way to measure what the pancreas itself is doing.
Standard range versus optimal range
| Framework | C-peptide value | Source |
|---|---|---|
| Standard fasting reference | about 0.5-2.0 ng/mL | Common laboratory range |
| Suggestive of insulin resistance | above roughly 2.0-3.0 ng/mL fasting | Clinical endocrinology literature |
| Suggestive of beta cell failure | below 0.2-0.3 ng/mL | Diabetes classification studies |
When it runs high
High C-peptide means the pancreas is producing abundant insulin, most often as compensation for insulin resistance. It typically accompanies high fasting insulin, abdominal weight gain and a fatty liver pattern.
- Insulin resistance and type 2 diabetes, early or compensated phase
- Obesity
- Kidney impairment, which slows C-peptide clearance
- Insulinoma when paired with low glucose
- Sulfonylurea medicines that push the pancreas harder
When it runs low
Low C-peptide indicates the pancreas is making little insulin of its own. Together with high glucose it confirms beta cell failure, which changes treatment because oral agents alone will not suffice.
- Type 1 diabetes or LADA
- Long-standing type 2 diabetes with beta cell exhaustion
- Pancreatectomy or chronic pancreatitis
- Low insulin need in very insulin-sensitive lean people, benign when glucose is normal
A proxy that outperforms the original
Insulin is secreted into the portal vein, half cleared by the liver on the first pass, and impossible to measure usefully in anyone injecting it. C-peptide sidesteps all three problems. It is released in equal molar amounts with insulin, escapes first-pass liver extraction, circulates five times longer, and is absent from every insulin vial. Endocrinologists use it to answer the practical question of whether a pancreas still produces insulin at all.
The diabetes classification workhorse
When diabetes type is uncertain, C-peptide often settles it. A value well below 0.3 ng/mL with high glucose points to autoimmune beta cell loss and the need for insulin, while a robust or high value supports type 2 physiology and opens the full menu of oral and injectable non-insulin options. The measurement is most informative when glucose is simultaneously elevated or after a stimulation test, since C-peptide appropriately runs low when glucose is low.
Reading it in metabolic health
Outside classification, a fasting C-peptide in the upper range quietly confirms what high fasting insulin suggests, that the pancreas is working overtime against resistance. Kidney function matters for interpretation, because impaired clearance can double the value without any extra production. Paired with fasting glucose and insulin it completes the early-warning picture of metabolic disease.
Related calculators
Related biomarkers Insulin · Glucose · HbA1c